Detalhe da pesquisa
1.
Bimekizumab versus Secukinumab in Plaque Psoriasis.
N Engl J Med
; 385(2): 142-152, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891380
2.
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.
Allergy
; 79(1): 174-183, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988255
3.
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS).
J Am Acad Dermatol
; 90(3): 494-503, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951245
4.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
J Am Acad Dermatol
; 90(5): 986-993, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253129
5.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
J Am Acad Dermatol
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556093
6.
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).
J Eur Acad Dermatol Venereol
; 38(5): 864-872, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179809
7.
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.
J Eur Acad Dermatol Venereol
; 38(2): 340-353, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669868
8.
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review.
J Cutan Med Surg
; 28(2): 134-135, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327060
9.
A Practical Guide to Using Biologics in Pediatric Dermatology.
J Cutan Med Surg
; 28(1): 59-67, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38229411
10.
Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
N Engl J Med
; 383(3): 229-239, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668113
11.
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials.
Br J Dermatol
; 188(3): 330-340, 2023 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36751950
12.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279795
13.
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
J Am Acad Dermatol
; 89(5): 927-935, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656094
14.
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.
J Am Acad Dermatol
; 88(1): 29-39, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820547
15.
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.
J Am Acad Dermatol
; 89(6): 1149-1158, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553030
16.
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
J Eur Acad Dermatol Venereol
; 37(4): 737-752, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606566
17.
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.
J Eur Acad Dermatol Venereol
; 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708097
18.
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
J Drugs Dermatol
; 22(2): 139-147, 2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745371
19.
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Pediatr Dermatol
; 40(3): 452-459, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949579
20.
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial.
Pediatr Dermatol
; 40(6): 1003-1009, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455588